GcMAF (Gc Protein-derived Macrophage Activating Factor)
Protein that activates macrophages to attack cancer cells and pathogens.
63/100
Nobuto Yamamoto
6-24 months
9 phases
4 targeted
Protocol Overview
Protein that activates macrophages to attack cancer cells and pathogens. Made from vitamin D binding protein. Controversial therapy shut down in multiple countries but still available from some sources.
Conditions Treated
Key Resources
Safety Profile
Major controversy - original researcher's papers retracted, producers raided and shut down. Quality and authenticity of current sources questionable. Some legitimate research interest remains.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.